VJOncology is committed to improving our service to you

WCCS/EADO 2016 | What is the future of melanoma immunotherapy

VJOncology is committed to improving our service to you

Brigitte Dréno

Brigitte Dréno, MD, PhD from the University Hospital of Nantes, Nantes, France discusses vaccination and T-cell adoptive therapies for the treatment of melanoma at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. Dr Dréno begins by introducing the subject of adoptive T-cell therapy and the new approaches focusing on specific antigens and inducing more reactive T-cells, by sorting and using clones, which are being researched currently. Dr Dréno believes that that in the future, vaccination and adoptive T-cell therapy will be used in combination, providing the example of T-cell therapy trials combined with anti PD-1 or oncolytic viruses. Dr Dréno suggests that for patients in the metastatic stages of their disease, future optimal therapies could involve a combination of targeted therapy with checkpoint inhibitors.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter